Teradyne (TER) EBT (2009 - 2026)

Teradyne (TER) has reported EBT for 18 consecutive years, with $443.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBT rose 359.43% year-over-year to $443.6 million; the trailing twelve-month figure through Jun 2026 stood at $1.3 billion (up 153.02% YoY), and the FY2025 full-year result was $653.3 million, up 7.25% from the prior year.
• EBT fell to $443.6 million in Q2 2026 per TER's latest filing, from $465.7 million in the prior quarter.
• Across five years, EBT topped out at $465.7 million in Q1 2026 and bottomed at $72.9 million in Q1 2024.
• Historically, EBT has averaged $196.5 million across 5 years, with a median of $158.4 million in 2024.
• The sharpest annual moves came in 2025 and 2026: EBT sank 55.99% in 2025, then surged 359.43% in 2026.
• Over 5 years, EBT stood at $195.2 million in 2022, then slipped by 28.39% to $139.8 million in 2023, then grew by 12.87% to $157.8 million in 2024, then jumped by 83.51% to $289.6 million in 2025, then soared by 53.2% to $443.6 million in 2026.
• According to Business Quant data, EBT over the past three periods registered $443.6 million, $465.7 million, and $289.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.